Urine sensor breakthrough could spare cancer patients from needles
NCT ID NCT01693861
First seen Jan 06, 2026 · Last updated Jun 14, 2026 · Updated 19 times
Summary
This study tested a new, non-invasive way to monitor chemotherapy effects in 16 people with advanced colorectal cancer. Researchers measured special substances in urine samples taken before and after treatment to see if they could track cancer activity without blood draws or scans. The goal was to explore whether a simple urine test could one day help doctors personalize cancer therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Paul Brousse Hospital
Villejuif, 94807, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.